HAMPTON LAINE Trademark

Trademark Overview


On Friday, April 12, 2024, a trademark application was filed for HAMPTON LAINE with the United States Patent and Trademark Office. The USPTO has given the HAMPTON LAINE trademark a serial number of 98497797. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, November 1, 2024. This trademark is owned by Prasco, LLC. The HAMPTON LAINE trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Use in Commerce) pharmaceutical preparations for the treatment of cardiovascular diseases and conditions; pharmaceutical preparations for the treatment of certain symptoms of menopause; (Based on Intent To Use) pharmaceutical preparations for the treatment of central nervous system diseases and disorders, pharmaceutical preparations for the treatment of psychotic disorders, pharmaceutical preparations for the treatment of schizophrenia, and pharmaceutical antipsychotic preparations; antidepressants; antibiotics; anti-inflammatory preparations; combination antibiotic used to treat a variety of bacterial infections; corticosteroid that reduces inflammation and suppresses the immune system; hormonal compound for medicinal and pharmaceutical use; medicines and pharmaceutical preparations for the treatment of mental disorders; medicines and pharmaceutical preparation for use in the treatment of mental illness; pharmaceutical preparations for use in the treatment of mental diseases...
hampton laine

General Information


Serial Number98497797
Word MarkHAMPTON LAINE
Filing DateFriday, April 12, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, November 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Services(Based on Use in Commerce) pharmaceutical preparations for the treatment of cardiovascular diseases and conditions; pharmaceutical preparations for the treatment of certain symptoms of menopause; (Based on Intent To Use) pharmaceutical preparations for the treatment of central nervous system diseases and disorders, pharmaceutical preparations for the treatment of psychotic disorders, pharmaceutical preparations for the treatment of schizophrenia, and pharmaceutical antipsychotic preparations; antidepressants; antibiotics; anti-inflammatory preparations; combination antibiotic used to treat a variety of bacterial infections; corticosteroid that reduces inflammation and suppresses the immune system; hormonal compound for medicinal and pharmaceutical use; medicines and pharmaceutical preparations for the treatment of mental disorders; medicines and pharmaceutical preparation for use in the treatment of mental illness; pharmaceutical preparations for use in the treatment of mental diseases, disorders, and conditions; pharmaceutical preparations for bacterial infections; pharmaceutical preparations for the prevention and treatment of inflammation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 12, 2024
Primary Code005
First Use Anywhere DateWednesday, September 8, 2021
First Use In Commerce DateWednesday, September 8, 2021

Trademark Owner History


Party NamePrasco, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMason, OH 45040

Trademark Events


Event DateEvent Description
Friday, April 12, 2024NEW APPLICATION ENTERED
Friday, April 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 28, 2024ASSIGNED TO EXAMINER
Friday, November 1, 2024NON-FINAL ACTION E-MAILED
Friday, November 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 1, 2024NON-FINAL ACTION WRITTEN